Current approaches to enhance glutamate transporter function and expression

Journal of Neurochemistry

Volumn 134, Issue 6, 2015, Pages 982-1007

  Fontana, Andréia C K ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

allosteric modulation; ceftriaxone; EAAT2 activator; excitotoxicity; glutamate transporter; Parawixin1

Indexed keywords

1 (3,3 DIMETHYL 1,2 DIOXOPENTYL) 2 PYRROLIDINECARBOXYLIC ACID 3 (3 PYRIDYL)PROPYL ESTER; 5 METHYL 1 NICOTINOYL 2 PYRAZOLINE; AMITRIPTYLINE; AMPICILLIN; CEFAZOLIN; CEFOPERAZONE; CEFTRIAXONE; CHEMICAL COMPOUND; CORTICOSTERONE; DEXAMETHASONE; ESTRADIOL; EXCITATORY AMINO ACID TRANSPORTER 2; GT 949; GT 951; GUANOSINE; HARMINE; HISTAMINE; MINOCYCLINE; NICERGOLINE; PARAWIXIN1; PROTEIN KINASE B; PYRIDAZINE DERIVATIVE; RAPAMYCIN; RETINOL; RILUZOLE; SULBACTAM; TAMOXIFEN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROIC ACID; VESICULAR GLUTAMATE TRANSPORTER 1;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; AUTISM; BIOLOGICAL FUNCTIONS; CEREBROVASCULAR ACCIDENT; DOWN REGULATION; EPILEPSY; EXCITOTOXICITY; HIV ASSOCIATED DEMENTIA; HUMAN; HUNTINGTON CHOREA; NEUROPATHIC PAIN; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; TRAUMATIC BRAIN INJURY; ANIMAL; BRAIN; HOMEOSTASIS; METABOLISM; PHYSIOLOGY; SYNAPTIC TRANSMISSION;

ANIMALS; BRAIN; EXCITATORY AMINO ACID TRANSPORTER 2; HOMEOSTASIS; HUMANS; SYNAPTIC TRANSMISSION;

EID: 84941804861     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.13200     Document Type: Article

References (345)

1. Abekawa T., Honda M., Ito K., Inoue T., and, Koyama T., (2002a) Effect of MS-153 on the development of behavioral sensitization to locomotion- and ataxia-inducing effects of phencyclidine. Psychopharmacology 160, 122-131.
2. Abekawa T., Honda M., Ito K., Inoue T., and, Koyama T., (2002b) Effect of MS-153 on the development of behavioral sensitization to stereotypy-inducing effect of phencyclidine. Brain Res. 926, 176-180.
3. Akbar M. T., Torp R., Danbolt N. C., Levy L. M., Meldrum B. S., and, Ottersen O. P., (1997) Expression of glial glutamate transporters GLT-1 and GLAST is unchanged in the hippocampus in fully kindled rats. Neuroscience 78, 351-359.
4. Akyuz N., Georgieva E. R., Zhou Z., et al., (2015) Transport domain unlocking sets the uptake rate of an aspartate transporter. Nature 518, 68-73.
5. Alhaddad H., Kim N. T., Aal-Aaboda M., Althobaiti Y. S., Leighton J., Boddu S. H., Wei Y., and, Sari Y., (2014) Effects of MS-153 on chronic ethanol consumption and GLT1 modulation of glutamate levels in male alcohol-preferring rats. Front. Behav. Neurosci. 8, 366.
6. Ambrosi G., Cerri S., and, Blandini F., (2014) A further update on the role of excitotoxicity in the pathogenesis of Parkinson's disease. J. Neural. Transm. 121, 849-859.
7. Anderson C. M., and, Swanson R. A., (2000) Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 32, 1-14.
8. Arriza J. L., Eliasof S., Kavanaugh M. P., and, Amara S. G., (1997) Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance. Proc. Natl Acad. Sci. USA 94, 4155-4160.
9. Arzberger T., Krampfl K., Leimgruber S., and, Weindl A., (1997) Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington's disease-an in situ hybridization study. J. Neuropathol. Exp. Neurol. 56, 440-454.
10. Assous M., Had-Aissouni L., Gubellini P., Melon C., Nafia I., Salin P., Kerkerian-Le-Goff L., and, Kachidian P., (2014) Progressive Parkinsonism by acute dysfunction of excitatory amino acid transporters in the rat substantia nigra. Neurobiol. Dis. 65, 69-81.
11. Azbill R. D., Mu X., and, Springer J. E., (2000) Riluzole increases high-affinity glutamate uptake in rat spinal cord synaptosomes. Brain Res. 871, 175-180.
12. Baker A. J., Moulton R. J., MacMillan V. H., and, Shedden P. M., (1993) Excitatory amino acids in cerebrospinal fluid following traumatic brain injury in humans. J. Neurosurg. 79, 369-372.
13. Bamford N. S., Zhang H., Schmitz Y., et al., (2004) Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals. Neuron 42, 653-663.
14. Banasr M., Chowdhury G. M., Terwilliger R., Newton S. S., Duman R. S., Behar K. L., and, Sanacora G., (2010) Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole. Mol. Psychiatry 15, 501-511.
15. Banerjee A., Silver L. E., Heneghan C., Welch S. J., Mehta Z., Banning A. P., and, Rothwell P. M., (2011) Relative familial clustering of cerebral versus coronary ischemic events. Circ. Cardiovasc. Genet. 4, 390-396.
16. Bates G., (2003) Huntingtin aggregation and toxicity in Huntington's disease. Lancet 361, 1642-1644.
17. Beart P. M., and, O'Shea R. D., (2007) Transporters for L-glutamate: an update on their molecular pharmacology and pathological involvement. Br. J. Pharmacol. 150, 5-17.
18. Beghi E., Bendotti C., and, Mennini T., (2006) New ideas for therapy in ALS: critical considerations. Amyotroph. Lateral Scler. 7, 126-127; discussion 127.
19. Bendotti C., Tortarolo M., Suchak S. K., Calvaresi N., Carvelli L., Bastone A., Rizzi M., Rattray M., and, Mennini T., (2001) Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels. J. Neurochem. 79, 737-746.
20. Benveniste H., Drejer J., Schousboe A., and, Diemer N. H., (1984) Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43, 1369-1374.
21. Beresford I. J., Parsons A. A., and, Hunter A. J., (2003) Treatments for stroke. Expert Opin. Emerg. Drugs 8, 103-122.
22. Berger U. V., and, Hediger M. A., (1998) Comparative analysis of glutamate transporter expression in rat brain using differential double in situ hybridization. Anat. Embryol. 198, 13-30.
23. Bergles D. E., and, Jahr C. E., (1997) Synaptic activation of glutamate transporters in hippocampal astrocytes. Neuron 19, 1297-1308.
24. Bergles D. E., Tzingounis A. V., and, Jahr C. E., (2002) Comparison of coupled and uncoupled currents during glutamate uptake by GLT-1 transporters. J. Neurosci. 22, 10153-10162.
25. Berry J. D., Shefner J. M., Conwit R., et al., (2013) Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis. PLoS ONE 8, e61177.
26. Billups B., and, Attwell D., (1996) Modulation of non-vesicular glutamate release by pH. Nature 379, 171-174.
27. Bjornsen L. P., Eid T., Holmseth S., Danbolt N. C., Spencer D. D., and, de Lanerolle N. C., (2007) Changes in glial glutamate transporters in human epileptogenic hippocampus: inadequate explanation for high extracellular glutamate during seizures. Neurobiol. Dis. 25, 319-330.
28. Bonde C., Noraberg J., Noer H., and, Zimmer J., (2005) Ionotropic glutamate receptors and glutamate transporters are involved in necrotic neuronal cell death induced by oxygen-glucose deprivation of hippocampal slice cultures. Neuroscience 136, 779-794.
29. Boudker O., Ryan R. M., Yernool D., Shimamoto K., and, Gouaux E., (2007) Coupling substrate and ion binding to extracellular gate of a sodium-dependent aspartate transporter. Nature 445, 387-393.
30. Bough K. J., Paquet M., Pare J. F., Hassel B., Smith Y., Hall R. A., and, Dingledine R., (2007) Evidence against enhanced glutamate transport in the anticonvulsant mechanism of the ketogenic diet. Epilepsy Res. 74, 232-236.
31. Bridges R. J., Kavanaugh M. P., and, Chamberlin A. R., (1999) A pharmacological review of competitive inhibitors and substrates of high-affinity, sodium-dependent glutamate transport in the central nervous system. Curr. Pharm. Des. 5, 363-379.
32. Brothers H. M., Bardou I., Hopp S. C., Kaercher R. M., Corona A. W., Fenn A. M., Godbout J. P., and, Wenk G. L., (2013) Riluzole partially rescues age-associated, but not LPS-induced, loss of glutamate transporters and spatial memory. J. Neuroimmune Pharmacol. 8, 1098-1105.
33. Brown J. I., Baker A. J., Konasiewicz S. J., and, Moulton R. J., (1998) Clinical significance of CSF glutamate concentrations following severe traumatic brain injury in humans. J. Neurotrauma 15, 253-263.
34. Browne S. E., and, Beal M. F., (2006) Oxidative damage in Huntington's disease pathogenesis. Antioxid. Redox Signal. 8, 2061-2073.
35. Bruijn L. I., Becher M. W., Lee M. K., et al., (1997) ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18, 327-338.
36. Bunch L., Erichsen M. N., and, Jensen A. A., (2009) Excitatory amino acid transporters as potential drug targets. Expert Opin. Ther. Targets 13, 719-731.
37. Burda J. E., Bernstein A. M., and, Sofroniew M. V., (2015) Astrocyte roles in traumatic brain injury. Exp. Neurol. pii: S0014-4886(15)00089-8. doi: 10.1016/j.expneurol.2015.03.020. [Epub ahead of print] PubMed PMID: 25828533.
38. Carbone M., Duty S., and, Rattray M., (2012a) Riluzole elevates GLT-1 activity and levels in striatal astrocytes. Neurochem. Int. 60, 31-38.
39. Carbone M., Duty S., and, Rattray M., (2012b) Riluzole neuroprotection in a Parkinson's disease model involves suppression of reactive astrocytosis but not GLT-1 regulation. BMC Neurosci. 13, 38.
40. Cavus I., Kasoff W. S., Cassaday M. P., Jacob R., Gueorguieva R., Sherwin R. S., Krystal J. H., Spencer D. D., and, Abi-Saab W. M., (2005) Extracellular metabolites in the cortex and hippocampus of epileptic patients. Ann. Neurol. 57, 226-235.
41. Chao X. D., Fei F., and, Fei Z., (2010) The role of excitatory amino acid transporters in cerebral ischemia. Neurochem. Res. 35, 1224-1230.
42. Chen W., Mahadomrongkul V., Berger U. V., Bassan M., DeSilva T., Tanaka K., Irwin N., Aoki C., and, Rosenberg P. A., (2004) The glutamate transporter GLT1a is expressed in excitatory axon terminals of mature hippocampal neurons. J. Neurosci. 24, 1136-1148.
43. Cheney J. A., Brown A. L., Bareyre F. M., Russ A. B., Weisser J. D., Ensinger H. A., Leusch A., Raghupathi R., and, Saatman K. E., (2000) The novel compound LOE 908 attenuates acute neuromotor dysfunction but not cognitive impairment or cortical tissue loss following traumatic brain injury in rats. J. Neurotrauma 17, 83-91.
44. Cheng C., Glover G., Banker G., and, Amara S. G., (2002) A novel sorting motif in the glutamate transporter excitatory amino acid transporter 3 directs its targeting in Madin-Darby canine kidney cells and hippocampal neurons. J. Neurosci. 22, 10643-10652.
45. Chotibut T., Davis R. W., Arnold J. C., Frenchek Z., Gurwara S., Bondada V., Geddes J. W., and, Salvatore M. F., (2014) Ceftriaxone increases glutamate uptake and reduces striatal tyrosine hydroxylase loss in 6-OHDA Parkinson's model. Mol. Neurobiol. 49, 1282-1292.
46. Chu K., Lee S. T., Sinn D. I., et al., (2007) Pharmacological induction of ischemic tolerance by glutamate transporter-1 (EAAT2) upregulation. Stroke 38, 177-182.
47. Cisneros I. E., and, Ghorpade A., (2014) Methamphetamine and HIV-1-induced neurotoxicity: role of trace amine associated receptor 1 cAMP signaling in astrocytes. Neuropharmacology 85, 499-507.
48. Clements J. D., (1996) Transmitter timecourse in the synaptic cleft: its role in central synaptic function. Trends Neurosci. 19, 163-171.
49. Clements J., Lester R., Tong G., Jahr C., and, Westbrook G., (1992) The time course of glutamate in the synaptic cleft. Science 258, 1498-1501.
50. Collins M., Lovell M. R., Iverson G. L., Ide T., and, Maroon J., (2006) Examining concussion rates and return to play in high school football players wearing newer helmet technology: a three-year prospective cohort study. Neurosurgery 58, 275-286; discussion 275-286.
51. Colton C. K., Kong Q., Lai L., Zhu M. X., Seyb K. I., Cuny G. D., Xian J., Glicksman M. A., and, Lin C. L., (2010) Identification of translational activators of glial glutamate transporter EAAT2 through cell-based high-throughput screening: an approach to prevent excitotoxicity. J. Biomol. Screen. 15, 653-662.
52. Conradt M., and, Stoffel W., (1997) Inhibition of the high-affinity brain glutamate transporter GLAST-1 via direct phosphorylation. J. Neurochem. 68, 1244-1251.
53. Coulter D. A., and, Eid T., (2012) Astrocytic regulation of glutamate homeostasis in epilepsy. Glia 60, 1215-1226.
54. Courchesne E., (1997) Brainstem, cerebellar and limbic neuroanatomical abnormalities in autism. Curr. Opin. Neurobiol. 7, 269-278.
55. Coutinho-Netto J., Abdul-Ghani A. S., Collins J. F., and, Bradford H. F., (1981) Is glutamate a trigger factor in epileptic hyperactivity? Epilepsia 22, 289-296.
56. Crunelli V., Carmignoto G., and, Steinhäuser C., (2015) Astrocytic targets provide new avenues for the therapeutic treatment of epilepsy. Neuroscientist 21, 62-83.
57. Cudkowicz M., Shefner J., and, Consortium N., (2013) STAGE 3 clinical trial of ceftriaxone in subjects with ALS (S36.001). Neurology 80 (Meeting Abstracts 1): S36.001.
58. Cui C., Cui Y., Gao J., et al., (2014) Neuroprotective effect of ceftriaxone in a rat model of traumatic brain injury. Neurol. Sci. 35, 695-700.
59. Cui X., Li L., Hu Y. Y., Ren S., Zhang M., and, Li W. B., (2015) Sulbactam plays neuronal protective effect against brain ischemia via upregulating GLT1 in rats. Mol. Neurobiol. 51, 1322-1333.
60. Dagci T., Yilmaz O., Taskiran D., and, Peker G., (2007) Neuroprotective agents: is effective on toxicity in glial cells? Cell. Mol. Neurobiol. 27, 171-177.
61. Danbolt N. C., (2001) Glutamate uptake. Prog. Neurobiol. 65, 1-105.
62. David Y., Cacheaux L. P., Ivens S., Lapilover E., Heinemann U., Kaufer D., and, Friedman A., (2009) Astrocytic dysfunction in epileptogenesis: consequence of altered potassium and glutamate homeostasis? J. Neurosci. 29, 10588-10599.
63. De Bundel D., Schallier A., Loyens E., et al., (2011) Loss of system x(c)- does not induce oxidative stress but decreases extracellular glutamate in hippocampus and influences spatial working memory and limbic seizure susceptibility. J. Neurosci. 31, 5792-5803.
64. Dehnes Y., Chaudhry F. A., Ullensvang K., Lehre K. P., Storm-Mathisen J., and, Danbolt N. C., (1998) The glutamate transporter EAAT4 in rat cerebellar Purkinje cells: a glutamate-gated chloride channel concentrated near the synapse in parts of the dendritic membrane facing astroglia. J. Neurosci. 18, 3606-3619.
65. Del Signore S. J., Amante D. J., Kim J., Stack E. C., Goodrich S., Cormier K., Smith K., Cudkowicz M. E., and, Ferrante R. J., (2009) Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice. Amyotroph. Lateral Scler. 10, 85-94.
66. Deumens R., Blokland A., and, Prickaerts J., (2002) Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp. Neurol. 175, 303-317.
67. Diamond J. S., and, Jahr C. E., (1997) Transporters buffer synaptically released glutamate on a submillisecond time scale. J. Neurosci. 17, 4672-4687.
68. During M. J., and, Spencer D. D., (1993) Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain. Lancet 341, 1607-1610.
69. Edwards R. H., (2015) Mobile binding sites regulate glutamate clearance. Nat. Neurosci. 18, 166-168.
70. Eid T., Thomas M. J., Spencer D. D., et al., (2004) Loss of glutamine synthetase in the human epileptogenic hippocampus: possible mechanism for raised extracellular glutamate in mesial temporal lobe epilepsy. Lancet 363, 28-37.
71. Eisenberg M. A., Andrea J., Meehan W., and, Mannix R., (2013) Time interval between concussions and symptom duration. Pediatrics 132, 8-17.
72. Eisenberg M. A., Meehan W. P., 3rd, and, Mannix R., (2014) Duration and course of post-concussive symptoms. Pediatrics 133, 999-1006.
73. Estrada G., Villegas E., and, Corzo G., (2007) Spider venoms: a rich source of acylpolyamines and peptides as new leads for CNS drugs. Nat. Prod. Rep. 24, 145-161.
74. Estrada-Sanchez A. M., and, Rebec G. V., (2012) Corticostriatal dysfunction and glutamate transporter 1 (GLT1) in Huntington's disease: interactions between neurons and astrocytes. Basal Ganglia 2, 57-66.
75. Estrada-Sanchez A. M., Montiel T., Segovia J., and, Massieu L., (2009) Glutamate toxicity in the striatum of the R6/2 Huntington's disease transgenic mice is age-dependent and correlates with decreased levels of glutamate transporters. Neurobiol. Dis. 34, 78-86.
76. Faden A. I., Demediuk P., Panter S. S., and, Vink R., (1989) The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 244, 798-800.
77. Faideau M., Kim J., Cormier K., et al., (2010) In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects. Hum. Mol. Genet. 19, 3053-3067.
78. Fairman W. A., Vandenberg R. J., Arriza J. L., Kavanaugh M. P., and, Amara S. G., (1995) An excitatory amino-acid transporter with properties of a ligand-gated chloride channel. Nature 375, 599-603.
79. Fang Q., Hu W. W., Wang X. F., et al., (2014) Histamine up-regulates astrocytic glutamate transporter 1 and protects neurons against ischemic injury. Neuropharmacology 77, 156-166.
80. Feng D., Wang W., Dong Y., et al., (2014a) Ceftriaxone alleviates early brain injury after subarachnoid hemorrhage by increasing excitatory amino acid transporter 2 expression via the PI3K/Akt/NF-kappaB signaling pathway. Neuroscience 268, 21-32.
81. Feng Y., Lu S., Wang J., Kumar P., Zhang L., and, Bhatt A. J., (2014b) Dexamethasone-induced neuroprotection in hypoxic-ischemic brain injury in newborn rats is partly mediated via Akt activation. Brain Res. 1589c, 68-77.
82. Figiel M., and, Engele J., (2000) Pituitary adenylate cyclase-activating polypeptide (PACAP), a neuron-derived peptide regulating glial glutamate transport and metabolism. J. Neurosci. 20, 3596-3605.
83. Finnie J., (2001) Animal models of traumatic brain injury: a review. Aust. Vet. J. 79, 628-633.
84. Fioravanti M., and, Flicker L., (2001) Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment. Cochrane Database Syst. Rev. 4, Cd003159.
85. Fioravanti M., Nakashima T., Xu J., and, Garg A., (2014) A systematic review and meta-analysis assessing adverse event profile and tolerability of nicergoline. BMJ open 4, e005090.
86. Fontana A. C., Guizzo R., de Oliveira Beleboni R., Meirelles E. S. A. R., Coimbra N. C., Amara S. G., dos Santos W. F., and, Coutinho-Netto J., (2003) Purification of a neuroprotective component of Parawixia bistriata spider venom that enhances glutamate uptake. Br. J. Pharmacol. 139, 1297-1309.
87. Fontana A. C., de Oliveira Beleboni R., Wojewodzic M. W., Ferreira Dos Santos W., Coutinho-Netto J., Grutle N. J., Watts S. D., Danbolt N. C., and, Amara S. G., (2007) Enhancing glutamate transport: mechanism of action of Parawixin1, a neuroprotective compound from Parawixia bistriata spider venom. Mol. Pharmacol. 72, 1228-1237.
88. Fontana A. C., Fox D. P., Zoubroulis A., Mortensen O. V., and, Raghupathi R., (2015) Neuroprotective effects of the glutamate transporter activator, MS-153, following traumatic brain injury in the adult rat. J. Neurotrauma doi: 10.1089/neu.2015.4079 [Epub ahead of print].
89. Frizzo M. E., Lara D. R., Dahm K. C., Prokopiuk A. S., Swanson R. A., and, Souza D. O., (2001) Activation of glutamate uptake by guanosine in primary astrocyte cultures. NeuroReport 12, 879-881.
90. Frizzo M. E., Dall'Onder L. P., Dalcin K. B., and, Souza D. O., (2004) Riluzole enhances glutamate uptake in rat astrocyte cultures. Cell. Mol. Neurobiol. 24, 123-128.
91. Frizzo M. E., Schwalm F. D., Frizzo J. K., Soares F. A., and, Souza D. O., (2005) Guanosine enhances glutamate transport capacity in brain cortical slices. Cell. Mol. Neurobiol. 25, 913-921.
92. Fumagalli E., Funicello M., Rauen T., Gobbi M., and, Mennini T., (2008) Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1. Eur. J. Pharmacol. 578, 171-176.
93. Furness D. N., Dehnes Y., Akhtar A. Q., et al., (2008) A quantitative assessment of glutamate uptake into hippocampal synaptic terminals and astrocytes: new insights into a neuronal role for excitatory amino acid transporter 2 (EAAT2). Neuroscience 157, 80-94.
94. Furuta A., Rothstein J. D., and, Martin L. J., (1997) Glutamate transporter protein subtypes are expressed differentially during rat CNS development. J. Neurosci. 17, 8363-8375.
95. Ganel R., Ho T., Maragakis N. J., Jackson M., Steiner J. P., and, Rothstein J. D., (2006) Selective up-regulation of the glial Na+-dependent glutamate transporter GLT1 by a neuroimmunophilin ligand results in neuroprotection. Neurobiol. Dis. 21, 556-567.
96. Gegelashvili G., and, Bjerrum O. J., (2014) High-affinity glutamate transporters in chronic pain: an emerging therapeutic target. J. Neurochem. 131, 712-730.
97. Gegelashvili G., Dehnes Y., Danbolt N. C., and, Schousboe A., (2000) The high-affinity glutamate transporters GLT1, GLAST, and EAAT4 are regulated via different signalling mechanisms. Neurochem. Int. 37, 163-170.
98. Gether U., Andersen P. H., Larsson O. M., and, Schousboe A., (2006) Neurotransmitter transporters: molecular function of important drug targets. Trends Pharmacol. Sci. 27, 375-383.
99. Ghanizadeh A., and, Berk M., (2015) Beta-lactam antibiotics as a possible novel therapy for managing epilepsy and autism, a case report and review of literature. Iran. J. Child Neurol. 9, 99-102.
100. Gincel D., Regan M. R., Jin L., Watkins A. M., Bergles D. E., and, Rothstein J. D., (2007) Analysis of cerebellar Purkinje cells using EAAT4 glutamate transporter promoter reporter in mice generated via bacterial artificial chromosome-mediated transgenesis. Exp. Neurol. 203, 205-212.
101. Ginsberg M. D., (2008) Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology 55, 363-389.
102. Giza C. C., Mink R. B., and, Madikians A., (2007) Pediatric traumatic brain injury: not just little adults. Curr. Opin. Crit. Care 13, 143-152.
103. Goodrich G. S., Kabakov A. Y., Hameed M. Q., Dhamne S. C., Rosenberg P. A., and, Rotenberg A., (2013) Ceftriaxone treatment after traumatic brain injury restores expression of the glutamate transporter, GLT-1, reduces regional gliosis, and reduces post-traumatic seizures in the rat. J. Neurotrauma 30, 1434-1441.
104. Grewer C., Gameiro A., Zhang Z., Tao Z., Braams S., and, Rauen T., (2008) Glutamate forward and reverse transport: from molecular mechanism to transporter-mediated release after ischemia. IUBMB Life 60, 609-619.
105. Grewer C., Gameiro A., and, Rauen T., (2014) SLC1 glutamate transporters. Pflugers Arch. 466, 3-24.
106. Guerriero R. M., Giza C. C., and, Rotenberg A., (2015) Glutamate and GABA imbalance following traumatic brain injury. Curr. Neurol. Neurosci. Rep. 15, 545.
107. Guo H., Lai L., Butchbach M. E., Stockinger M. P., Shan X., Bishop G. A., and, Lin C. L., (2003) Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice. Hum. Mol. Genet. 12, 2519-2532.
108. Guo F., Sun F., Yu J. L., et al., (2010) Abnormal expressions of glutamate transporters and metabotropic glutamate receptor 1 in the spontaneously epileptic rat hippocampus. Brain Res. Bull. 81, 510-516.
109. Gupta R. K., and, Prasad S., (2014) Differential regulation of GLT-1/EAAT2 gene expression by NF-kappaB and N-myc in male mouse brain during postnatal development. Neurochem. Res. 39, 150-160.
110. Gurney M. E., Cutting F. B., Zhai P., Doble A., Taylor C. P., Andrus P. K., and, Hall E. D., (1996) Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann. Neurol. 39, 147-157.
111. Hakuba N., Koga K., Gyo K., Usami S. I., and, Tanaka K., (2000) Exacerbation of noise-induced hearing loss in mice lacking the glutamate transporter GLAST. J. Neurosci. 20, 8750-8753.
112. Hansel G., Tonon A. C., Guella F. L., Pettenuzzo L. F., Duarte T., Duarte M. M., Oses J. P., Achaval M., and, Souza D. O., (2014) Guanosine protects against cortical focal ischemia. Involvement of inflammatory response. Mol. Neurobiol. PMID: 25394382.
113. Hardingham G. E., and, Bading H., (2010) Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat. Rev. Neurosci. 11, 682-696.
114. Hardy J., Cowburn R., Barton A., Reynolds G., Lofdahl E., O'Carroll A. M., Wester P., and, Winblad B., (1987) Region-specific loss of glutamate innervation in Alzheimer's disease. Neurosci. Lett. 73, 77-80.
115. Harvey B. K., Airavaara M., Hinzman J., et al., (2011) Targeted over-expression of glutamate transporter 1 (GLT-1) reduces ischemic brain injury in a rat model of stroke. PLoS ONE 6, e22135.
116. Hassel B., Iversen E. G., Gjerstad L., and, Tauboll E., (2001) Up-regulation of hippocampal glutamate transport during chronic treatment with sodium valproate. J. Neurochem. 77, 1285-1292.
117. Haugeto O., Ullensvang K., Levy L. M., Chaudhry F. A., Honore T., Nielsen M., Lehre K. P., and, Danbolt N. C., (1996) Brain glutamate transporter proteins form homomultimers. J. Biol. Chem. 271, 27715-27722.
118. Hazell A. S., (2007) Excitotoxic mechanisms in stroke: an update of concepts and treatment strategies. Neurochem. Int. 50, 941-953.
119. van der Hel W. S., Notenboom R. G., Bos I. W., van Rijen P. C., van Veelen C. W., and, de Graan P. N., (2005) Reduced glutamine synthetase in hippocampal areas with neuron loss in temporal lobe epilepsy. Neurology 64, 326-333.
120. Herman M. A., and, Jahr C. E., (2007) Extracellular glutamate concentration in hippocampal slice. J. Neurosci. 27, 9736-9741.
121. Hogan D. B., (2014) Long-term efficacy and toxicity of cholinesterase inhibitors in the treatment of Alzheimer disease. Can. J. Psychiatry 59, 618-623.
122. Holmseth S., Dehnes Y., Huang Y. H., et al., (2012) The density of EAAC1 (EAAT3) glutamate transporters expressed by neurons in the mammalian CNS. J. Neurosci. 32, 6000-6013.
123. Hosseinzadeh Z., Bhavsar S. K., Sopjani M., Alesutan I., Saxena A., Dermaku-Sopjani M., and, Lang F., (2011) Regulation of the glutamate transporters by JAK2. Cell. Physiol. Biochem. 28, 693-702.
124. Hota S. K., Barhwal K., Ray K., Singh S. B., and, Ilavazhagan G., (2008) Ceftriaxone rescues hippocampal neurons from excitotoxicity and enhances memory retrieval in chronic hypobaric hypoxia. Neurobiol. Learn. Mem. 89, 522-532.
125. Hu Y., Li W., Lu L., Cai J., Xian X., Zhang M., Li Q., and, Li L., (2010) An anti-nociceptive role for ceftriaxone in chronic neuropathic pain in rats. Pain 148, 284-301.
126. Hu Y. Y., Xu J., Zhang M., Wang D., Li L., and, Li W. B., (2015) Ceftriaxone modulates uptake activity of glial glutamate transporter-1 against global brain ischemia in rats. J. Neurochem. 132, 194-205.
127. Huh J. W., and, Raghupathi R., (2009) New concepts in treatment of pediatric traumatic brain injury. Anesthesiol. Clin. 27, 213-240.
128. Hynd M. R., Scott H. L., and, Dodd P. R., (2004) Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem. Int. 45, 583-595.
129. Ikematsu K., Tsuda R., Kondo T., and, Nakasono I., (2002) The expression of excitatory amino acid transporter 2 in traumatic brain injury. Forensic Sci. Int. 130, 83-89.
130. Ikonomidou C., and, Turski L., (2002) Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol. 1, 383-386.
131. Izumi Y., Shimamoto K., Benz A. M., Hammerman S. B., Olney J. W., and, Zorumski C. F., (2002) Glutamate transporters and retinal excitotoxicity. Glia 39, 58-68.
132. Jabaudon D., Scanziani M., Gahwiler B. H., and, Gerber U., (2000) Acute decrease in net glutamate uptake during energy deprivation. Proc. Natl Acad. Sci. USA 97, 5610-5615.
133. Jabs R., Seifert G., and, Steinhauser C., (2008) Astrocytic function and its alteration in the epileptic brain. Epilepsia 49 (Suppl 2), 3-12.
134. Jagadapillai R., Mellen N. M., Sachleben L. R., Jr, and, Gozal E., (2014) Ceftriaxone preserves glutamate transporters and prevents intermittent hypoxia-induced vulnerability to brain excitotoxic injury. PLoS ONE 9, e100230.
135. Jensen A. A., Fahlke C., Bjorn-Yoshimoto W. E., and, Bunch L., (2015) Excitatory amino acid transporters: recent insights into molecular mechanisms, novel modes of modulation and new therapeutic possibilities. Curr. Opin. Pharmacol. 20, 116-123.
136. Ji Y. F., Zhou L., Xie Y. J., et al., (2013) Upregulation of glutamate transporter GLT-1 by mTOR-Akt-NF-small ka, CyrillicB cascade in astrocytic oxygen-glucose deprivation. Glia 61, 1959-1975.
137. Jimenez E., Nunez E., Ibanez I., Draffin J. E., Zafra F., and, Gimenez C., (2014) Differential regulation of the glutamate transporters GLT-1 and GLAST by GSK3beta. Neurochem. Int. 79, 33-43.
138. Kaila K., Ruusuvuori E., Seja P., Voipio J., and, Puskarjov M., (2014) GABA actions and ionic plasticity in epilepsy. Curr. Opin. Neurobiol. 26, 34-41.
139. Kanai Y., and, Hediger M. A., (1992) Primary structure and functional characterization of a high-affinity glutamate transporter. Nature 360, 467-471.
140. Kanner B. I., (1983) Bioenergetics of neurotransmitter transport. Biochim. Biophys. Acta 726, 293-316.
141. Kanner B. I., (1989) Ion-coupled neurotransmitter transport. Curr. Opin. Cell Biol. 1, 735-738.
142. Kanner B. I., and, Schuldiner S., (1987) Mechanism of transport and storage of neurotransmitters. CRC Crit. Rev. Biochem. 22, 1-38.
143. Karki P., Webb A., Smith K., Lee K., Son D. S., Aschner M., and, Lee E., (2013) cAMP response element-binding protein (CREB) and nuclear factor kappaB mediate the tamoxifen-induced up-regulation of glutamate transporter 1 (GLT-1) in rat astrocytes. J. Biol. Chem. 288, 28975-28986.
144. Karki P., Smith K., Johnson J., Jr, and, Lee E., (2014) Astrocyte-derived growth factors and estrogen neuroprotection: role of transforming growth factor-alpha in estrogen-induced upregulation of glutamate transporters in astrocytes. Mol. Cell. Endocrinol. 389, 58-64.
145. Katagiri H., Tanaka K., and, Manabe T., (2001) Requirement of appropriate glutamate concentrations in the synaptic cleft for hippocampal LTP induction. Eur. J. Neuorsci. 14, 547-553.
146. Katayama Y., Becker D. P., Tamura T., and, Hovda D. A., (1990) Massive increases in extracellular potassium and the indiscriminate release of glutamate following concussive brain injury. J. Neurosurg. 73, 889-900.
147. Kawazura H., Takahashi Y., Shiga Y., Shimada F., Ohto N., and, Tamura A., (1997) Cerebroprotective effects of a novel pyrazoline derivative, MS-153, on focal ischemia in rats. Jpn. J. Pharmacol. 73, 317-324.
148. Kelsey J. E., and, Neville C., (2014) The effects of the beta-lactam antibiotic, ceftriaxone, on forepaw stepping and L-DOPA-induced dyskinesia in a rodent model of Parkinson's disease. Psychopharmacology 231, 2405-2415.
149. 2+-homeostasis of brain neurons caused by toxic glutamate challenge. Membr. Cell Biol. 14, 149-162.
150. Kim K., Lee S. G., Kegelman T. P., et al., (2011) Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics. J. Cell. Physiol. 226, 2484-2493.
151. Kimura A., Guo X., Noro T., Harada C., Tanaka K., Namekata K., and, Harada T., (2015) Valproic acid prevents retinal degeneration in a murine model of normal tension glaucoma. Neurosci. Lett. 588, 108-113.
152. Kiryk A., Aida T., Tanaka K., et al., (2008) Behavioral characterization of GLT1 (+/-) mice as a model of mild glutamatergic hyperfunction. Neurotox. Res. 13, 19-30.
153. Kong Q., Takahashi K., Schulte D., Stouffer N., Lin Y., and, Lin C. L., (2012) Increased glial glutamate transporter EAAT2 expression reduces epileptogenic processes following pilocarpine-induced status epilepticus. Neurobiol. Dis. 47, 145-154.
154. Kong Q., Chang L. C., Takahashi K., et al., (2014) Small-molecule activator of glutamate transporter EAAT2 translation provides neuroprotection. J. Clin. Investig. 124, 1255-1267.
155. Kosugi T., and, Kawahara K., (2006) Reversed actrocytic GLT-1 during ischemia is crucial to excitotoxic death of neurons, but contributes to the survival of astrocytes themselves. Neurochem. Res. 31, 933-943.
156. Kristensen A. S., Andersen J., Jorgensen T. N., Sorensen L., Eriksen J., Loland C. J., Stromgaard K., and, Gether U., (2011) SLC6 neurotransmitter transporters: structure, function, and regulation. Pharmacol. Rev. 63, 585-640.
157. Krzyzanowska W., Pomierny B., Filip M., and, Pera J., (2014) Glutamate transporters in brain ischemia: to modulate or not? Acta Pharmacol. Sin. 35, 444-462.
158. Kulijewicz-Nawrot M., Sykova E., Chvatal A., Verkhratsky A., and, Rodriguez J. J., (2013) Astrocytes and glutamate homoeostasis in Alzheimer's disease: a decrease in glutamine synthetase, but not in glutamate transporter-1, in the prefrontal cortex. ASN Neuro. 5, 273-282.
159. Kumar A., Singh A., and, Ekavali, (2015) A review on Alzheimer's disease pathophysiology and its management: an update. Pharmacol. Rep. 67, 195-203.
160. van Landeghem F. K., Weiss T., Oehmichen M., and, von Deimling A., (2006) Decreased expression of glutamate transporters in astrocytes after human traumatic brain injury. J. Neurotrauma 23, 1518-1528.
161. de Lanerolle N. C., Kim J. H., and, Bandak F. A., (2015) Neuropathology of traumatic brain injury: comparison of penetrating, nonpenetrating direct impact and explosive blast etiologies. Semin. Neurol. 35, 012-019.
162. Larsson H. P., Tzingounis A. V., Koch H. P., and, Kavanaugh M. P., (2004) Fluorometric measurements of conformational changes in glutamate transporters. Proc. Natl Acad. Sci. USA 101, 3951-3956.
163. Lauderback C. M., Hackett J. M., Huang F. F., Keller J. N., Szweda L. I., Markesbery W. R., and, Butterfield D. A., (2001) The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42. J. Neurochem. 78, 413-416.
164. Lauriat T. L., and, McInnes L. A., (2007) EAAT2 regulation and splicing: relevance to psychiatric and neurological disorders. Mol. Psychiatry 12, 1065-1078.
165. Lebrun B., Sakaitani M., Shimamoto K., Yasuda-Kamatani Y., and, Nakajima T., (1997) New beta-hydroxyaspartate derivatives are competitive blockers for the bovine glutamate/aspartate transporter. J. Biol. Chem. 272, 20336-20339.
166. Lee S. G., Su Z. Z., Emdad L., Gupta P., Sarkar D., Borjabad A., Volsky D. J., and, Fisher P. B., (2008) Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes. J. Biol. Chem. 283, 13116-13123.
167. Lee E., Sidoryk-Wegrzynowicz M., Farina M., Rocha J. B., and, Aschner M., (2013) Estrogen attenuates manganese-induced glutamate transporter impairment in rat primary astrocytes. Neurotox. Res. 23, 124-130.
168. Lehre K. P., and, Danbolt N. C., (1998) The number of glutamate transporter subtype molecules at glutamatergic synapses: chemical and stereological quantification in young adult rat brain. J. Neurosci. 18, 8751-8757.
169. Lehre K. P., Levy L. M., Ottersen O. P., Storm-Mathisen J., and, Danbolt N. C., (1995) Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations. J. Neurosci. 15, 1835-1853.
170. Leung T. C., Lui C. N., Chen L. W., Yung W. H., Chan Y. S., and, Yung K. K., (2012) Ceftriaxone ameliorates motor deficits and protects dopaminergic neurons in 6-hydroxydopamine-lesioned rats. ACS Chem. Neurosci. 3, 22-30.
171. Levy L. M., Lehre K. P., Walaas S. I., Storm-Mathisen J., and, Danbolt N. C., (1995) Down-regulation of glial glutamate transporters after glutamatergic denervation in the rat brain. Eur. J. Neuorsci. 7, 2036-2041.
172. Levy L. M., Warr O., and, Attwell D., (1998) Stoichiometry of the glial glutamate transporter GLT-1 expressed inducibly in a Chinese hamster ovary cell line selected for low endogenous Na+-dependent glutamate uptake. J. Neurosci. 18, 9620-9628.
173. Li S., Mallory M., Alford M., Tanaka S., and, Masliah E., (1997) Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression. J. Neuropathol. Exp. Neurol. 56, 901-911.
174. Li X., Inouei T., Abekawai T., YiRui F., and, Koyama T., (2004) Effect of MS-153 on the acquisition and expression of conditioned fear in rats. Eur. J. Pharmacol. 505, 145-149.
175. Li L. B., Toan S. V., Zelenaia O., Watson D. J., Wolfe J. H., Rothstein J. D., and, Robinson M. B., (2006) Regulation of astrocytic glutamate transporter expression by Akt: evidence for a selective transcriptional effect on the GLT-1/EAAT2 subtype. J. Neurochem. 97, 759-771.
176. Li Y., Sattler R., Yang E. J., Nunes A., Ayukawa Y., Akhtar S., Ji G., Zhang P. W., and, Rothstein J. D., (2011) Harmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expression. Neuropharmacology 60, 1168-1175.
177. Li Y., Zhou Y., and, Danbolt N. C., (2012) The rates of postmortem proteolysis of glutamate transporters differ dramatically between cells and between transporter subtypes. J. Histochem. Cytochem. 60, 811-821.
178. Li D., Herault K., Silm K., Evrard A., Wojcik S., Oheim M., Herzog E., and, Ropert N., (2013) Lack of evidence for vesicular glutamate transporter expression in mouse astrocytes. J. Neurosci. 33, 4434-4455.
179. Li K., Hala T. J., Seetharam S., Poulsen D. J., Wright M. C., and, Lepore A. C., (2015) GLT1 overexpression in SOD1 (G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease. Neurobiol. Dis. 78, 12-23.
180. Lima F. D., Souza M. A., Furian A. F., et al., (2008) Na+, K+-ATPase activity impairment after experimental traumatic brain injury: relationship to spatial learning deficits and oxidative stress. Behav. Brain Res. 193, 306-310.
181. Lipski J., Wan C. K., Bai J. Z., Pi R., Li D., and, Donnelly D., (2007) Neuroprotective potential of ceftriaxone in in vitro models of stroke. Neuroscience 146, 617-629.
182. Lopes M. W., Soares F. M., de Mello N., et al., (2013) Time-dependent modulation of AMPA receptor phosphorylation and mRNA expression of NMDA receptors and glial glutamate transporters in the rat hippocampus and cerebral cortex in a pilocarpine model of epilepsy. Exp. Brain Res. 226, 153-163.
183. Lopez-Bayghen E., and, Ortega A., (2011) Glial glutamate transporters: new actors in brain signaling. IUBMB Life 63, 816-823.
184. Louzada-Junior P., Dias J. J., Santos W. F., Lachat J. J., Bradford H. F., and, Coutinho-Netto J., (1992) Glutamate release in experimental ischaemia of the retina: an approach using microdialysis. J. Neurochem. 59, 358-363.
185. Lu Z., Zhang W., Zhang N., Jiang J., Luo Q., and, Qiu Y., (2008) The expression of glutamate transporters in chest compression-induced audiogenic epilepsy: a comparative study. Neurol. Res. 30, 915-919.
186. Machtens J. P., Kortzak D., Lansche C., et al., (2015) Mechanisms of anion conduction by coupled glutamate transporters. Cell 160, 542-553.
187. Maeda S., Kawamoto A., Yatani Y., Shirakawa H., Nakagawa T., and, Kaneko S., (2008) Gene transfer of GLT-1, a glial glutamate transporter, into the spinal cord by recombinant adenovirus attenuates inflammatory and neuropathic pain in rats. Mol. Pain. 4, 65.
188. Mao Q. X., and, Yang T. D., (2010) Amitriptyline upregulates EAAT1 and EAAT2 in neuropathic pain rats. Brain Res. Bull. 81, 424-427.
189. Maragakis N. J., Dykes-Hoberg M., and, Rothstein J. D., (2004) Altered expression of the glutamate transporter EAAT2b in neurological disease. Ann. Neurol. 55, 469-477.
190. Mark L. P., Prost R. W., Ulmer J. L., Smith M. M., Daniels D. L., Strottmann J. M., Brown W. D., and, Hacein-Bey L., (2001) Pictorial review of glutamate excitotoxicity: fundamental concepts for neuroimaging. AJNR Am. J. Neuroradiol. 22, 1813-1824.
191. Massie A., Goursaud S., Schallier A., Vermoesen K., Meshul C. K., Hermans E., and, Michotte Y., (2010) Time-dependent changes in GLT-1 functioning in striatum of hemi-Parkinson rats. Neurochem. Int. 57, 572-578.
192. Massieu L., and, Garcia O., (1998) The role of excitotoxicity and metabolic failure in the pathogenesis of neurological disorders. Neurobiology (Bp) 6, 99-108.
193. Mathern G. W., Mendoza D., Lozada A., et al., (1999) Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy. Neurology 52, 453-472.
194. Matos-Ocasio F., Hernandez-Lopez A., and, Thompson K. J., (2014) Ceftriaxone, a GLT-1 transporter activator, disrupts hippocampal learning in rats. Pharmacol. Biochem. Behav. 122, 118-121.
195. Matsugami T. R., Tanemura K., Mieda M., et al., (2006) From the cover: indispensability of the glutamate transporters GLAST and GLT1 to brain development. Proc. Natl Acad. Sci. USA 103, 12161-12166.
196. Mattson M. P., and, Chan S. L., (2003) Neuronal and glial calcium signaling in Alzheimer's disease. Cell Calcium 34, 385-397.
197. Matute C., Domercq M., and, Sanchez-Gomez M. V., (2006) Glutamate-mediated glial injury: mechanisms and clinical importance. Glia 53, 212-224.
198. McEntee W. J., and, Crook T. H., (1993) Glutamate: its role in learning, memory, and the aging brain. Psychopharmacology 111, 391-401.
199. McIntosh T. K., Vink R., Soares H., Hayes R., and, Simon R., (1990) Effect of noncompetitive blockade of N-methyl-D-aspartate receptors on the neurochemical sequelae of experimental brain injury. J. Neurochem. 55, 1170-1179.
200. McIntosh T. K., Smith D. H., Voddi M., Perri B. R., and, Stutzmann J. M., (1996) Riluzole, a novel neuroprotective agent, attenuates both neurologic motor and cognitive dysfunction following experimental brain injury in the rat. J. Neurotrauma 13, 767-780.
201. Medvedev N., Popov V., Henneberger C., Kraev I., Rusakov D. A., and, Stewart M. G., (2014) Glia selectively approach synapses on thin dendritic spines. Philos. Trans. R. Soc. Lond. B Biol. Sci. 369, 20140047.
202. Meeker K. D., Meabon J. S., and, Cook D. G., (2015) Partial loss of the glutamate transporter GLT-1 alters brain Akt and insulin signaling in a mouse model of Alzheimer's disease. J. Alzheimers Dis. 45, 509-520.
203. Mehta A., Prabhakar M., Kumar P., Deshmukh R., and, Sharma P. L., (2013) Excitotoxicity: bridge to various triggers in neurodegenerative disorders. Eur. J. Pharmacol. 698, 6-18.
204. Meldrum B., and, Garthwaite J., (1990) Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol. Sci. 11, 379-387.
205. Melzer N., Meuth S. G., Torres-Salazar D., et al., (2008) A beta-lactam antibiotic dampens excitotoxic inflammatory CNS damage in a mouse model of multiple sclerosis. PLoS ONE 3, e3149.
206. Miller H. P., Levey A. I., Rothstein J. D., Tzingounis A. V., and, Conn P. J., (1997) Alterations in glutamate transporter protein levels in kindling-induced epilepsy. J. Neurochem. 68, 1564-1570.
207. Miller R. G., Mitchell J. D., and, Moore D. H., (2000) Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst. Rev. 2, CD001447.
208. Miller B. R., Dorner J. L., Shou M., Sari Y., Barton S. J., Sengelaub D. R., Kennedy R. T., and, Rebec G. V., (2008) Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouse. Neuroscience 153, 329-337.
209. Miller B. R., Dorner J. L., Bunner K. D., Gaither T. W., Klein E. L., Barton S. J., and, Rebec G. V., (2012a) Up-regulation of GLT1 reverses the deficit in cortically evoked striatal ascorbate efflux in the R6/2 mouse model of Huntington's disease. J. Neurochem. 121, 629-638.
210. Miller R. G., Mitchell J. D., and, Moore D. H., (2012b) Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst. Rev. 3, CD001447.
211. Mitani A., and, Tanaka K., (2003) Functional changes of glial glutamate transporter GLT-1 during ischemia: an in vivo study in the hippocampal CA1 of normal mice and mutant mice lacking GLT-1. J. Neurosci. 23, 7176-7182.
212. Mookherjee P., Green P. S., Watson G. S., et al., (2011) GLT-1 loss accelerates cognitive deficit onset in an Alzheimer's disease animal model. J. Alzheimers Dis. 26, 447-455.
213. Moretto M. B., Arteni N. S., Lavinsky D., Netto C. A., Rocha J. B., Souza D. O., and, Wofchuk S., (2005) Hypoxic-ischemic insult decreases glutamate uptake by hippocampal slices from neonatal rats: prevention by guanosine. Exp. Neurol. 195, 400-406.
214. Mortensen O. V., Liberato J. L., Coutinho-Netto J., Dos Santos W. F., and, Fontana A. C., (2015) Molecular determinants of transport stimulation of EAAT2 are located at interface between the trimerization and substrate transport domains. J. Neurochem. 133, 199-210.
215. Mu X., Azbill R. D., and, Springer J. E., (2000) Riluzole and methylprednisolone combined treatment improves functional recovery in traumatic spinal cord injury. J. Neurotrauma 17, 773-780.
216. Murphy-Royal C., Dupuis J. P., Varela J. A., Panatier A., Pinson B., Baufreton J., Groc L., and, Oliet S. H., (2015) Surface diffusion of astrocytic glutamate transporters shapes synaptic transmission. Nat. Neurosci. 18, 219-226.
217. Nakagawa T., Ozawa T., Shige K., Yamamoto R., Minami M., and, Satoh M., (2001) Inhibition of morphine tolerance and dependence by MS-153, a glutamate transporter activator. Eur. J. Pharmacol. 419, 39-45.
218. Nakagawa T., Fujio M., Ozawa T., Minami M., and, Satoh M., (2005) Effect of MS-153, a glutamate transporter activator, on the conditioned rewarding effects of morphine, methamphetamine and cocaine in mice. Behav. Brain Res. 156, 233-239.
219. Nederkoorn P. J., Westendorp W. F., Hooijenga I. J., et al., (2011) Preventive antibiotics in stroke study: rationale and protocol for a randomised trial. Int. J. Stroke 6, 159-163.
220. Nie H., Zhang H., and, Weng H. R., (2010) Minocycline prevents impaired glial glutamate uptake in the spinal sensory synapses of neuropathic rats. Neuroscience 170, 901-912.
221. Nilsson E., Alafuzoff I., Blennow K., et al., (1990a) Calpain and calpastatin in normal and Alzheimer-degenerated human brain tissue. Neurobiol. Aging 11, 425-431.
222. Nilsson P., Hillered L., Ponten U., and, Ungerstedt U., (1990b) Changes in cortical extracellular levels of energy-related metabolites and amino acids following concussive brain injury in rats. J. Cereb. Blood Flow Metab. 10, 631-637.
223. Nishida A., Iwata H., Kudo Y., Kobayashi T., Matsuoka Y., Kanai Y., and, Endou H., (2004) Nicergoline enhances glutamate uptake via glutamate transporters in rat cortical synaptosomes. Biol. Pharm. Bull. 27, 817-820.
224. Nishizawa Y., (2001) Glutamate release and neuronal damage in ischemia. Life Sci. 69, 369-381.
225. de O Beleboni R., Pizzo A. B., Fontana A. C., Carolino R. O., Coutinho-Netto J., and, Dos Santos W. F., (2004) Spider and wasp neurotoxins: pharmacological and biochemical aspects. Eur. J. Pharmacol. 493, 1-17.
226. Okiyama K., Smith D. H., Thomas M. J., and, McIntosh T. K., (1992) Evaluation of a novel calcium channel blocker, (S)-emopamil, on regional cerebral edema and neurobehavioral function after experimental brain injury. J. Neurosurg. 77, 607-615.
227. Okiyama K., Smith D. H., White W. F., Richter K., and, McIntosh T. K., (1997) Effects of the novel NMDA antagonists CP-98,113, CP-101,581 and CP-101,606 on cognitive function and regional cerebral edema following experimental brain injury in the rat. J. Neurotrauma 14, 211-222.
228. Okiyama K., Smith D. H., White W. F., and, McIntosh T. K., (1998) Effects of the NMDA antagonist CP-98,113 on regional cerebral edema and cardiovascular, cognitive, and neurobehavioral function following experimental brain injury in the rat. Brain Res. 792, 291-298.
229. O'Shea R. D., Fodera M. V., Aprico K., Dehnes Y., Danbolt N. C., Crawford D., and, Beart P. M., (2002) Evaluation of drugs acting at glutamate transporters in organotypic hippocampal cultures: new evidence on substrates and blockers in excitotoxicity. Neurochem. Res. 27, 5-13.
230. Oster S., Radad K., Scheller D., Hesse M., Balanzew W., Reichmann H., and, Gille G., (2014) Rotigotine protects against glutamate toxicity in primary dopaminergic cell culture. Eur. J. Pharmacol. 724, 31-42.
231. Otis T. S., and, Kavanaugh M. P., (2000) Isolation of current components and partial reaction cycles in the glial glutamate transporter EAAT2. J. Neurosci. 20, 2749-2757.
232. Palmen S. J., van Engeland H., Hof P. R., and, Schmitz C., (2004) Neuropathological findings in autism. Brain 127, 2572-2583.
233. Palmer A. M., Marion D. W., Botscheller M. L., Swedlow P. E., Styren S. D., and, DeKosky S. T., (1993) Traumatic brain injury-induced excitotoxicity assessed in a controlled cortical impact model. J. Neurochem. 61, 2015-2024.
234. Pan X. D., Wei J., and, Xiao G. M., (2011) [Effects of beta-lactam antibiotics ceftriaxone on expression of glutamate in hippocampus after traumatic brain injury in rats. Zhejiang Da Xue Xue Bao Yi Xue Ban 40, 522-526.
235. Peng S., Zhang Y., Zhang J., Wang H., and, Ren B., (2011) Glutamate receptors and signal transduction in learning and memory. Mol. Biol. Rep. 38, 453-460.
236. Petr G. T., Schultheis L. A., Hussey K. C., Sun Y., Dubinsky J. M., Aoki C., and, Rosenberg P. A., (2013) Decreased expression of GLT-1 in the R6/2 model of Huntington's disease does not worsen disease progression. Eur. J. Neuorsci. 38, 2477-2490.
237. Petr G. T., Sun Y., Frederick N. M., et al., (2015) Conditional deletion of the glutamate transporter GLT-1 reveals that astrocytic GLT-1 protects against fatal epilepsy while neuronal GLT-1 contributes significantly to glutamate uptake into synaptosomes. J. Neurosci. 35, 5187-5201.
238. Phillis J. W., and, O'Regan M. H., (1996) Mechanisms of glutamate and aspartate release in the ischemic rat cerebral cortex. Brain Res. 730, 150-164.
239. Pignataro G., Capone D., Polichetti G., Vinciguerra A., Gentile A., Di Renzo G., and, Annunziato L., (2011) Neuroprotective, immunosuppressant and antineoplastic properties of mTOR inhibitors: current and emerging therapeutic options. Curr. Opin. Pharmacol. 11, 378-394.
240. Pines G., Danbolt N. C., Bjoras M., et al., (1992) Cloning and expression of a rat brain L-glutamate transporter. Nature 360, 464-467.
241. Potter M. C., Figuera-Losada M., Rojas C., and, Slusher B. S., (2013) Targeting the glutamatergic system for the treatment of HIV-associated neurocognitive disorders. J. Neuroimmune Pharmacol. 8, 594-607.
242. Proper E. A., Hoogland G., Kappen S. M., et al., (2002) Distribution of glutamate transporters in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy. Brain 125, 32-43.
243. Qu S., and, Kanner B. I., (2008) Substrates and non-transportable analogues induce structural rearrangements at the extracellular entrance of the glial glutamate transporter GLT-1/EAAT2. J. Biol. Chem. 283, 26391-26400.
244. Raghupathi R., (2004) Cell death mechanisms following traumatic brain injury. Brain Pathol. 14, 215-222.
245. Rao V. L., Baskaya M. K., Dogan A., Rothstein J. D., and, Dempsey R. J., (1998) Traumatic brain injury down-regulates glial glutamate transporter (GLT-1 and GLAST) proteins in rat brain. J. Neurochem. 70, 2020-2027.
246. Rao V. L., Dogan A., Bowen K. K., Todd K. G., and, Dempsey R. J., (2001) Antisense knockdown of the glial glutamate transporter GLT-1 exacerbates hippocampal neuronal damage following traumatic injury to rat brain. Eur. J. Neuorsci. 13, 119-128.
247. Rao V. R., Ruiz A. P., and, Prasad V. R., (2014) Viral and cellular factors underlying neuropathogenesis in HIV associated neurocognitive disorders (HAND). AIDS Res. Ther. 11, 13.
248. Rao P. S., Goodwani S., Bell R. L., Wei Y., Boddu S. H., and, Sari Y., (2015) Effects of ampicillin, cefazolin and cefoperazone treatments on GLT1 expressions in the mesocorticolimbic system and ethanol intake in alcohol-preferring rats. Neuroscience 295, 164-174.
249. Rebec G. V., (2013) Dysregulation of corticostriatal ascorbate release and glutamate uptake in transgenic models of Huntington's disease. Antioxid. Redox Signal. 19, 2115-2128.
250. Reyes N., Ginter C., and, Boudker O., (2009) Transport mechanism of a bacterial homologue of glutamate transporters. Nature 462, 880-885.
251. Reyes N., Oh S., and, Boudker O., (2013) Binding thermodynamics of a glutamate transporter homolog. Nat. Struct. Mol. Biol. 20, 634-640.
252. Robelet S., Melon C., Guillet B., Salin P., and, Kerkerian-Le Goff L., (2004) Chronic L-DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson's disease. Eur. J. Neuorsci. 20, 1255-1266.
253. Rodriguez M. C., Obeso J. A., and, Olanow C. W., (1998) Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection. Ann. Neurol. 44, S175-S188.
254. Rosenberg P. A., Amin S., and, Leitner M., (1992) Glutamate uptake disguises neurotoxic potency of glutamate agonists in cerebral cortex in dissociated cell culture. J. Neurosci. 12, 56-61.
255. Rossi D. J., Oshima T., and, Attwell D., (2000) Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature 403, 316-321.
256. Rothman S. M., and, Olney J. W., (1995) Excitotoxicity and the NMDA receptor-still lethal after eight years. Trends Neurosci. 18, 57-58.
257. Rothstein J. D., (1995a) Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis. Adv. Neurol. 68, 7-20; discussion 21-27.
258. Rothstein J. D., (1995b) Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis. Clin. Neurosci. 3, 348-359.
259. Rothstein J. D., Martin L. J., and, Kuncl R. W., (1992) Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N. Engl. J. Med. 326, 1464-1468.
260. Rothstein J. D., Martin L., Levey A. I., Dykes-Hoberg M., Jin L., Wu D., Nash N., and, Kuncl R. W., (1994) Localization of neuronal and glial glutamate transporters. Neuron 13, 713-725.
261. Rothstein J. D., Van Kammen M., Levey A. I., Martin L. J., and, Kuncl R. W., (1995) Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 38, 73-84.
262. Rothstein J. D., Dykes-Hoberg M., Pardo C. A., et al., (1996) Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16, 675-686.
263. Rothstein J. D., Patel S., Regan M. R., et al., (2005) Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433, 73-77.
264. Rusakov D. A., Savtchenko L. P., Zheng K., and, Henley J. M., (2011) Shaping the synaptic signal: molecular mobility inside and outside the cleft. Trends Neurosci. 34, 359-369.
265. Sabri F., Titanji K., De Milito A., and, Chiodi F., (2003) Astrocyte activation and apoptosis: their roles in the neuropathology of HIV infection. Brain Pathol. 13, 84-94.
266. Sari Y., and, Sreemantula S. N., (2012) Neuroimmunophilin GPI-1046 reduces ethanol consumption in part through activation of GLT1 in alcohol-preferring rats. Neuroscience 227, 327-335.
267. Sato H., Tamba M., Okuno S., Sato K., Keino-Masu K., Masu M., and, Bannai S., (2002) Distribution of cystine/glutamate exchange transporter, system x(c)-, in the mouse brain. J. Neurosci. 22, 8028-8033.
268. Sato H., Shiiya A., Kimata M., et al., (2005) Redox imbalance in cystine/glutamate transporter-deficient mice. J. Biol. Chem. 280, 37423-37429.
269. Schallier A., Smolders I., Van Dam D., Loyens E., De Deyn P. P., Michotte A., Michotte Y., and, Massie A., (2011) Region- and age-specific changes in glutamate transport in the AbetaPP23 mouse model for Alzheimer's disease. J. Alzheimers Dis. 24, 287-300.
270. Scimemi A., Meabon J. S., Woltjer R. L., Sullivan J. M., Diamond J. S., and, Cook D. G., (2013) Amyloid-beta1-42 slows clearance of synaptically released glutamate by mislocalizing astrocytic GLT-1. J. Neurosci. 33, 5312-5318.
271. Scofield M. D., and, Kalivas P. W., (2014) Astrocytic dysfunction and addiction: consequences of impaired glutamate homeostasis. Neuroscientist 20, 610-622.
272. Scott H. A., Gebhardt F. M., Mitrovic A. D., Vandenberg R. J., and, Dodd P. R., (2011) Glutamate transporter variants reduce glutamate uptake in Alzheimer's disease. Neurobiol. Aging 32, 553.e551-511.
273. Sheldon A. L., and, Robinson M. B., (2007) The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem. Int. 51, 333-355.
274. Shigeri Y., Seal R. P., and, Shimamoto K., (2004) Molecular pharmacology of glutamate transporters, EAATs and VGLUTs. Brain Res. Brain Res. Rev. 45, 250-265.
275. Shimada F., Shiga Y., Morikawa M., Kawazura H., Morikawa O., Matsuoka T., Nishizaki T., and, Saito N., (1999) The neuroprotective agent MS-153 stimulates glutamate uptake. Eur. J. Pharmacol. 386, 263-270.
276. Shimamoto K., (2008) Glutamate transporter blockers for elucidation of the function of excitatory neurotransmission systems. Chem. Rec. 8, 182-199.
277. Shimamoto K., Lebrun B., Yasuda-Kamatani Y., Sakaitani M., Shigeri Y., Yumoto N., and, Nakajima T., (1998) DL-threo-beta-benzyloxyaspartate, a potent blocker of excitatory amino acid transporters. Mol. Pharmacol. 53, 195-201.
278. Shin J. Y., Fang Z. H., Yu Z. X., Wang C. E., Li S. H., and, Li X. J., (2005) Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J. Cell. Biol. 171, 1001-1012.
279. Simantov R., Crispino M., Hoe W., Broutman G., Tocco G., Rothstein J. D., and, Baudry M., (1999) Changes in expression of neuronal and glial glutamate transporters in rat hippocampus following kainate-induced seizure activity. Brain Res. Mol. Brain Res. 65, 112-123.
280. Sisk D. R., and, Kuwabara T., (1985) Histologic changes in the inner retina of albino rats following intravitreal injection of monosodium L-glutamate. Graefes Arch. Clin. Exp. Ophthalmol. 223, 250-258.
281. Soares H. D., Thomas M., Cloherty K., and, McIntosh T. K., (1992) Development of prolonged focal cerebral edema and regional cation changes following experimental brain injury in the rat. J. Neurochem. 58, 1845-1852.
282. Storck T., Schulte S., Hofmann K., and, Stoffel W., (1992) Structure, expression, and functional analysis of a Na(+)-dependent glutamate/aspartate transporter from rat brain. Proceedings of the National Academy of Sciences of the United States of America 89, 10955-10959.
283. Suchak S. K., Baloyianni N. V., Perkinton M. S., Williams R. J., Meldrum B. S., and, Rattray M., (2003) The 'glial' glutamate transporter, EAAT2 (Glt-1) accounts for high affinity glutamate uptake into adult rodent nerve endings. J. Neurochem. 84, 522-532.
284. Sun P., Zhang S., Li Y., and, Wang L., (2014) Harmine mediated neuroprotection via evaluation of glutamate transporter 1 in a rat model of global cerebral ischemia. Neurosci. Lett. 583c, 32-36.
285. Szatkowski M., and, Attwell D., (1994) Triggering and execution of neuronal death in brain ischaemia: two phases of glutamate release by different mechanisms. Trends Neurosci. 17, 359-365.
286. Szatkowski M., Barbour B., and, Attwell D., (1990) Non-vesicular release of glutamate from glial cells by reversed electrogenic glutamate uptake. Nature 348, 443-446.
287. Szatmari P., Paterson A. D., Zwaigenbaum L., (2007) Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat. Genet. 39, 319-328.
288. Talantova M., Sanz-Blasco S., Zhang X., et al., (2013) Abeta induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss. Proc. Natl Acad. Sci. USA 110, E2518-E2527.
289. Tanaka K., Watase K., Manabe T., et al., (1997) Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276, 1699-1702.
290. Tao Y. X., Gu J., and, Stephens R. L., Jr, (2005) Role of spinal cord glutamate transporter during normal sensory transmission and pathological pain states. Mol. Pain. 1, 30.
291. Taoufik E., and, Probert L., (2008) Ischemic neuronal damage. Curr. Pharm. Des. 14, 3565-3573.
292. Tessler S., Danbolt N. C., Faull R. L., Storm-Mathisen J., and, Emson P. C., (1999) Expression of the glutamate transporters in human temporal lobe epilepsy. Neuroscience 88, 1083-1091.
293. Thone-Reineke C., Neumann C., Namsolleck P., et al., (2008) The beta-lactam antibiotic, ceftriaxone, dramatically improves survival, increases glutamate uptake and induces neurotrophins in stroke. J. Hypertens. 26, 2426-2435.
294. Tian G., Lai L., Guo H., Lin Y., Butchbach M. E., Chang Y., and, Lin C. L., (2007) Translational control of glial glutamate transporter EAAT2 expression. J. Biol. Chem. 282, 1727-1737.
295. Traynor B. J., Bruijn L., Conwit R., Beal F., O'Neill G., Fagan S. C., and, Cudkowicz M. E., (2006) Neuroprotective agents for clinical trials in ALS: a systematic assessment. Neurology 67, 20-27.
296. Trotti D., Rolfs A., Danbolt N. C., Brown R. H., Jr, and, Hediger M. A., (1999a) SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter. Nat. Neurosci. 2, 848.
297. Trotti D., Rolfs A., Danbolt N. C., Brown R. H., Jr, and, Hediger M. A., (1999b) SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter. Nat. Neurosci. 2, 427-433.
298. Trotti D., Aoki M., Pasinelli P., Berger U. V., Danbolt N. C., Brown R. H., Jr, and, Hediger M. A., (2001) Amyotrophic lateral sclerosis-linked glutamate transporter mutant has impaired glutamate clearance capacity. J. Biol. Chem. 276, 576-582.
299. Ueda Y., Doi T., Nagatomo K., Willmore L. J., and, Nakajima A., (2007) Functional role for redox in the epileptogenesis: molecular regulation of glutamate in the hippocampus of FeCl3-induced limbic epilepsy model. Exp. Brain Res. 181, 571-577.
300. Uenishi H., Huang C. S., Song J. H., Marszalec W., and, Narahashi T., (1999) Ion channel modulation as the basis for neuroprotective action of MS-153. Ann. N. Y. Acad. Sci. 890, 385-399.
301. Ullensvang K., Lehre K. P., Storm-Mathisen J., and, Danbolt N. C., (1997) Differential Developmental Expression of the Two Rat Brain Glutamate Transporter Proteins GLAST and GLT. Eur. J. Neurosci. 9, 1646-1655.
302. Umemura K., Gemba T., Mizuno A., and, Nakashima M., (1996) Inhibitory effect of MS-153 on elevated brain glutamate level induced by rat middle cerebral artery occlusion. Stroke 27, 1624-1628.
303. Van Den Bosch L., Van Damme P., Bogaert E., and, Robberecht W., (2006) The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. Biochim. Biophys. Acta 1762, 1068-1082.
304. Vandenberg R. J., and, Ryan R. M., (2013) Mechanisms of glutamate transport. Physiol. Rev. 93, 1621-1657.
305. Verche V. L., Ikiz B., Jacquier A., Przedborski S., and, Re D. B., (2011) Glutamate pathway implication in amyotrophic lateral sclerosis: what is the signal in the noise? J. Recept. Ligang Channel Res. 4, 1-22.
306. Verdon G., and, Boudker O., (2012) Crystal structure of an asymmetric trimer of a bacterial glutamate transporter homolog. Nat. Struct. Mol. Biol. 19, 355-357.
307. Verma R., Mishra V., Sasmal D., and, Raghubir R., (2010) Pharmacological evaluation of glutamate transporter 1 (GLT-1) mediated neuroprotection following cerebral ischemia/reperfusion injury. Eur. J. Pharmacol. 638, 65-71.
308. Veruki M. L., Morkve S. H., and, Hartveit E., (2006) Activation of a presynaptic glutamate transporter regulates synaptic transmission through electrical signaling. Nat. Neurosci. 9, 1388-1396.
309. Vespa P., Prins M., Ronne-Engstrom E., Caron M., Shalmon E., Hovda D. A., Martin N. A., and, Becker D. P., (1998) Increase in extracellular glutamate caused by reduced cerebral perfusion pressure and seizures after human traumatic brain injury: a microdialysis study. J. Neurosurg. 89, 971-982.
310. Volterra A., Trotti D., Tromba C., Floridi S., and, Racagni G., (1994) Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J. Neurosci. 14, 2924-2932.
311. Wadiche J. I., Amara S. G., and, Kavanaugh M. P., (1995a) Ion fluxes associated with excitatory amino acid transport. Neuron 15, 721-728.
312. Wadiche J. I., Arriza J. L., Amara S. G., and, Kavanaugh M. P., (1995b) Kinetics of a human glutamate transporter. Neuron 14, 1019-1027.
313. Waibel S., Reuter A., Malessa S., Blaugrund E., and, Ludolph A. C., (2004) Rasagiline alone and in combination with riluzole prolongs survival in an ALS mouse model. J. Neurol. 251, 1080-1084.
314. Walker F. O., (2007) Huntington's disease. Lancet 369, 218-228.
315. Wang Y., and, Qin Z. H., (2010) Molecular and cellular mechanisms of excitotoxic neuronal death. Apoptosis 15, 1382-1402.
316. Wei J., Pan X., Pei Z., Wang W., Qiu W., Shi Z., and, Xiao G., (2012) The beta-lactam antibiotic, ceftriaxone, provides neuroprotective potential via anti-excitotoxicity and anti-inflammation response in a rat model of traumatic brain injury. J. Trauma Acute Care Surg. 73, 654-660.
317. Weiler I. J., Hawrylak N., and, Greenough W. T., (1995) Morphogenesis in memory formation: synaptic and cellular mechanisms. Behav. Brain Res. 66, 1-6.
318. Wen Z. H., Wu G. J., Chang Y. C., Wang J. J., and, Wong C. S., (2005) Dexamethasone modulates the development of morphine tolerance and expression of glutamate transporters in rats. Neuroscience 133, 807-817.
319. Weng H. R., Gao M., and, Maixner D. W., (2014) Glycogen synthase kinase 3 beta regulates glial glutamate transporter protein expression in the spinal dorsal horn in rats with neuropathic pain. Exp. Neurol. 252, 18-27.
320. Werner F. M., and, Covenas R., (2015) Review: classical neurotransmitters and neuropeptides involved in generalized epilepsy in a multi-neurotransmitter system: how to improve the antiepileptic effect? Epilepsy Behav. pii: S1525-5050(15)00045-1. doi: 10.1016/j.yebeh.2015.01.038.
321. Werner C., and, Engelhard K., (2007) Pathophysiology of traumatic brain injury. Br. J. Anaesth. 99, 4-9.
322. Wetherington J., Serrano G., and, Dingledine R., (2008) Astrocytes in the Epileptic Brain. Neuron 58, 168-178.
323. Wilson J. R., and, Fehlings M. G., (2014) Riluzole for acute traumatic spinal cord injury: a promising neuroprotective treatment strategy. World Neurosurg. 81, 825-829.
324. Wilson J. M., Khabazian I., Pow D. V., Craig U. K., and, Shaw C. A., (2003) Decrease in glial glutamate transporter variants and excitatory amino acid receptor down-regulation in a murine model of ALS-PDC. NeuroMol. Med. 3, 105-118.
325. Wisman L. A., van Muiswinkel F. L., de Graan P. N., Hol E. M., and, Bar P. R., (2003) Cells over-expressing EAAT2 protect motoneurons from excitotoxic death in vitro. NeuroReport 14, 1967-1970.
326. Woltjer R. L., Duerson K., Fullmer J. M., et al., (2010) Aberrant detergent-insoluble excitatory amino acid transporter 2 accumulates in Alzheimer disease. J. Neuropathol. Exp. Neurol. 69, 667-676.
327. Wong M., (2013) Mammalian target of rapamycin (mTOR) pathways in neurological diseases. Biomed. J. 36, doi: 10.4103/2319-4170.110365.
328. Wong M., Ess K. C., Uhlmann E. J., Jansen L. A., Li W., Crino P. B., Mennerick S., Yamada K. A., and, Gutmann D. H., (2003) Impaired glial glutamate transport in a mouse tuberous sclerosis epilepsy model. Ann. Neurol. 54, 251-256.
329. Wu X., Kihara T., Akaike A., Niidome T., and, Sugimoto H., (2010) PI3K/Akt/mTOR signaling regulates glutamate transporter 1 in astrocytes. Biochem. Biophys. Res. Commun. 393, 514-518.
330. Xing X., Chang L. C., Kong Q., Colton C. K., Lai L., Glicksman M. A., Lin C. L., and, Cuny G. D., (2011) Structure-activity relationship study of pyridazine derivatives as glutamate transporter EAAT2 activators. Bioorg. Med. Chem. Lett. 21, 5774-5777.
331. Yamamoto T., Rossi S., Stiefel M., Doppenberg E., Zauner A., Bullock R., and, Marmarou A., (1999) CSF and ECF glutamate concentrations in head injured patients. Acta Neurochir. Suppl. 75, 17-19.
332. Yernool D., Boudker O., Jin Y., and, Gouaux E., (2004) Structure of a glutamate transporter homologue from Pyrococcus horikoshii. Nature 431, 811-818.
333. Yi J. H., and, Hazell A. S., (2006) Excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injury. Neurochem. Int. 48, 394-403.
334. Yoshizumi M., Eisenach J. C., and, Hayashida K., (2013) Valproate prevents dysregulation of spinal glutamate and reduces the development of hypersensitivity in rats after peripheral nerve injury. J. Pain. 14, 1485-1491.
335. Zeidan-Chulia F., Salmina A. B., Malinovskaya N. A., Noda M., Verkhratsky A., and, Moreira J. C., (2014) The glial perspective of autism spectrum disorders. Neurosci. Biobehav. Rev. 38, 160-172.
336. Zelenaia O., Schlag B. D., Gochenauer G. E., Ganel R., Song W., Beesley J. S., Grinspan J. B., Rothstein J. D., and, Robinson M. B., (2000) Epidermal growth factor receptor agonists increase expression of glutamate transporter GLT-1 in astrocytes through pathways dependent on phosphatidylinositol 3-kinase and transcription factor NF-kappaB. Mol. Pharmacol. 57, 667-678.
337. Zerangue N., and, Kavanaugh M. P., (1996) Flux coupling in a neuronal glutamate transporter. Nature 383, 634-637.
338. Zhang C., Raghupathi R., Saatman K. E., Smith D. H., Stutzmann J. M., Wahl F., and, McIntosh T. K., (1998) Riluzole attenuates cortical lesion size, but not hippocampal neuronal loss, following traumatic brain injury in the rat. J. Neurosci. Res. 52, 342-349.
339. Zhou Y., and, Danbolt N. C., (2013) GABA and glutamate transporters in brain. Front. Endocrinol. 4, 165.
340. Zhou Y., and, Danbolt N. C., (2014) Glutamate as a neurotransmitter in the healthy brain. J. Neural. Transm. 121, 799-817.
341. Zhou Y., Waanders L. F., Holmseth S., Guo C., Berger U. V., Li Y., Lehre A. C., Lehre K. P., and, Danbolt N. C., (2014a) Proteome analysis and conditional deletion of the EAAT2 glutamate transporter provide evidence against a role of EAAT2 in pancreatic insulin secretion in mice. J. Biol. Chem. 289, 1329-1344.
342. Zhou Y., Wang X., Tzingounis A. V., Danbolt N. C., and, Larsson H. P., (2014b) EAAT2 (GLT-1; slc1a2) glutamate transporters reconstituted in liposomes argues against heteroexchange being substantially faster than net uptake. J. Neurosci. 34, 13472-13485.
343. Zimmer E. R., Kalinine E., Haas C. B., Torrez V. R., Souza D. O., Muller A. P., and, Portela L. V., (2012) Pretreatment with memantine prevents Alzheimer-like alterations induced by intrahippocampal okadaic acid administration in rats. Curr. Alzheimer Res. 9, 1182-1190.
344. Zlotnik A., Sinelnikov I., Gruenbaum B. F., et al., (2012) Effect of glutamate and blood glutamate scavengers oxaloacetate and pyruvate on neurological outcome and pathohistology of the hippocampus after traumatic brain injury in rats. Anesthesiology 116, 73-83.
345. Zschocke J., Bayatti N., Clement A. M., Witan H., Figiel M., Engele J., and, Behl C., (2005) Differential promotion of glutamate transporter expression and function by glucocorticoids in astrocytes from various brain regions. J. Biol. Chem. 280, 34924-34932.